about
Elevated risk of type 2 diabetes for development of Alzheimer disease: a key role for oxidative stress in brainIncreased Alzheimer's disease neuropathology is associated with type 2 diabetes and ApoE ε.4 carrier status.Diabetes mellitus and Alzheimer's disease: shared pathology and treatment?Non-invasive screening for Alzheimer's disease by sensing salivary sugar using Drosophila cells expressing gustatory receptor (Gr5a) immobilized on an extended gate ion-sensitive field-effect transistor (EG-ISFET) biosensor.The Effect of Lipoic Acid Therapy on Cognitive Functioning in Patients with Alzheimer's Disease.Huntington's disease biomarker progression profile identified by transcriptome sequencing in peripheral blood.Glycation exacerbates the neuronal toxicity of β-amyloid.Regulation of synaptic functions in central nervous system by endocrine hormones and the maintenance of energy homoeostasis.Novel Roles for the Insulin-Regulated Glucose Transporter-4 in Hippocampally Dependent Memory.Pioglitazone ameliorates memory deficits in streptozotocin-induced diabetic mice by reducing brain β-amyloid through PPARγ activationPossible implications of insulin resistance and glucose metabolism in Alzheimer's disease pathogenesis.Prioritizing tests of epistasis through hierarchical representation of genomic redundancies.Common neurodegenerative pathways in obesity, diabetes, and Alzheimer's disease.Inflammatory hypothesis as a link between Alzheimer's disease and diabetes mellitus.The inositol phosphatase SHIP2 negatively regulates insulin/IGF-I actions implicated in neuroprotection and memory function in mouse brain.Amylin receptor: a common pathophysiological target in Alzheimer's disease and diabetes mellitusNeuroprotective actions of glucagon-like peptide-1 in differentiated human neuroprogenitor cells.Exendin-4, a glucagon-like peptide-1 receptor agonist, reduces Alzheimer disease-associated tau hyperphosphorylation in the hippocampus of rats with type 2 diabetes.PPARγ agonist pioglitazone reverses memory impairment and biochemical changes in a mouse model of type 2 diabetes mellitus.Type 2 Diabetes Mellitus and Alzheimer's Disease: Overlapping Biologic Mechanisms and Environmental Risk Factors.Word-stem priming and recognition in type 2 diabetes mellitus, Alzheimer's disease patients and healthy older adults.
P2860
Q27003253-AD358D6E-78C5-4118-AA1E-22E16A07EF16Q33927061-EF086683-7ECF-48C6-9431-339D642D9D4BQ34608998-E34BC0CE-B925-4593-899F-E65C5CDA0B8DQ35123008-97837368-02D9-4F97-988E-ECB30228811AQ35623427-DD93BC99-E811-471F-B486-776BE5E9C60BQ36116666-D4F63F05-AF51-4CEA-B95F-D0ED1545A8CFQ36973739-6E73CA53-7042-4110-A609-55A5EA630751Q37246456-C4075F9D-9AC9-4318-BA26-A8BADF3F0354Q37445092-164DFE2C-DDAF-49AE-8434-26358384086BQ37728905-2D6BE10A-9EAF-44DD-8D4C-F453F5DA7D8BQ37857377-593FDFDF-C021-41AE-A872-F94400EED5ADQ38729879-45C483BE-9A89-43D6-9E87-00CFBA0ABB83Q38828830-BB257A95-90D9-421F-819C-EA71697BA0C6Q40534455-F0BA1E2B-FF7E-4765-9354-A0C23026C332Q41847084-D23C1ED3-288D-434C-93CB-AD8CC68911AEQ42078473-67FC098E-292C-4A1F-91F8-20C9B15A0949Q48358888-A103C288-6484-4E3B-A8AA-E6BED07A02F3Q48422656-9E1C443C-1A6C-40D6-860E-99D180A32295Q48497036-A5B790A2-DF05-4E4D-B123-7AA312E693BAQ49721822-32B874BE-EF66-4A64-ABF9-F809B9AC52A9Q50572130-8CCD3DB1-EDF5-4B01-8741-8452B2401F85
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Linking type 2 diabetes and Alzheimer's disease.
@ast
Linking type 2 diabetes and Alzheimer's disease.
@en
type
label
Linking type 2 diabetes and Alzheimer's disease.
@ast
Linking type 2 diabetes and Alzheimer's disease.
@en
prefLabel
Linking type 2 diabetes and Alzheimer's disease.
@ast
Linking type 2 diabetes and Alzheimer's disease.
@en
P2860
P356
P1476
Linking type 2 diabetes and Alzheimer's disease.
@en
P2093
P2860
P304
P356
10.1073/PNAS.1002555107
P407
P577
2010-04-12T00:00:00Z